At Roche Pharmaceuticals, we focus on finding new medicines that help patients live longer, better lives and evolve the practice of medicine.
This page lists Roche Australia’s pharmaceutical medicines. Use the search function to search by active ingredient, brand name or disease area, to find the Product Information (PI) and Consumer Medicine Information (CMI) for each product.
- Actemra® (tocilizumab)
-
Actemra® (tocilizumab)
Availability of Actemra® (tocilizumab):
- Pre-filled syringe for subcutaneous (SC) injection
- Pre-filled pen for subcutaneous (SC) injection
- Intravenous (IV) solution for infusion
Actemra® (tocilizumab) pre-filled syringe for subcutaneous (SC) injection
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Actemra® (tocilizumab) pre-filled pen for subcutaneous (SC) injection
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Actemra® (tocilizumab) intravenous (IV) solution for infusion
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Alecensa® (alectinib)
-
Alecensa® (alectinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Avastin® (bevacizumab)
-
Avastin® (bevacizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Bactrim® (sulfamethoxazole and trimethoprim)
-
Bactrim® (sulfamethoxazole and trimethoprim)
Roche has discontinued the supply of Bactrim (sulfamethoxazole/trimethoprim) oral suspension 200 mg/ 40 mg per 5 mL and Bactrim DS tablets 800/160mg. Stock of Bactrim oral suspension has now been depleted and it is anticipated that stock of Bactrim tablets will be depleted by end of July 2019. Alternative brands of sulfamethoxazole/trimethoprim are available from generic manufacturers.
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - CellCept® (mycophenolate mofetil)
-
CellCept® (mycophenolate mofetil)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Cotellic® (cobimetinib)
-
Cotellic® (cobimetinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Cymevene® (ganciclovir)
-
Cymevene® (ganciclovir)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Erivedge® (vismodegib)
-
Erivedge® (vismodegib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Esbriet® (pirfenidone)
-
Esbriet® (pirfenidone)
Availability of Esbriet® (pirfenidone):
- Tablets
- Capsules
Esbriet® (pirfenidone) tablets
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Esbriet® (pirfenidone) capsules
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Fuzeon® (enfuvirtide)
-
Fuzeon® (enfuvirtide)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Gazyva® (obinutuzumab)
-
Gazyva® (obinutuzumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Hemlibra® (emicizumab)
-
Hemlibra® (emicizumab)
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Herceptin® (trastuzumab) powder for IV infusion
-
Herceptin® (trastuzumab) powder for IV infusion
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Herceptin® SC (trastuzumab) solution for SC injection
-
Herceptin® SC (trastuzumab) solution for SC injection
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Hypnovel® (midazolam)
-
Hypnovel® (midazolam)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Invirase® (saquinavir)
-
Invirase® (saquinavir)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
- Kadcyla® (trastuzumab emtansine)
-
Kadcyla® (trastuzumab emtansine)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Konakion® MM (phytomenadione)
-
Konakion® MM (phytomenadione)
In November 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Konakion® MM (phytomenadione) to Pharmaco (Australia) Ltd within Australia.
The current Consumer Medicine Information (CMI) and Product Information (PI) for Konakion are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/
- Konakion® MM Paediatric (phytomenadione)
-
Konakion® MM Paediatric (phytomenadione)
In November 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Konakion® MM (phytomenadione) to Pharmaco (Australia) Ltd within Australia.
The current Consumer Medicine Information (CMI) and Product Information (PI) for Konakion are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/
- Lariam® (mefloquine)
-
Lariam® (mefloquine)
In August 2018, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Lariam (mefloquine) to Pharmaco (Australia) Limited within Australia.
- Lexotan® (bromazepam)
-
Lexotan® (bromazepam)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - MabThera® (rituximab) solution for IV infusion
-
MabThera® (rituximab) solution for IV infusion
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - MabThera® SC (rituximab) solution for SC injection
-
MabThera® SC (rituximab) solution for SC injection
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Madopar® (levodopa and benserazide)
-
Madopar® (levodopa and benserazide)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Mircera® (methoxy polyethylene glycolepoetin beta)
-
Mircera® (methoxy polyethylene glycolepoetin beta)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - NeoRecormon® (epoetin beta)
-
NeoRecormon® (epoetin beta)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Ocrevus® (ocrelizumab)
-
Ocrevus® (ocrelizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Pegasys® (peginterferon alfa-2a)
-
Pegasys® (peginterferon alfa-2a)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Perjeta® (pertuzumab)
-
Perjeta® (pertuzumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Pulmozyme® (dornase alfa)
-
Pulmozyme® (dornase alfa)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Rivotril® (clonazepam)
-
Rivotril® (clonazepam)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Roaccutane® (isotretinoin)
-
Roaccutane® (isotretinoin)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Rocaltrol® (calcitriol)
-
Rocaltrol® (calcitriol)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Roferon-A® (interferon alfa-2a)
-
Roferon-A® (interferon alfa-2a)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tamiflu® (oseltamivir) capsules
-
Tamiflu® (oseltamivir) capsules
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tamiflu® (oseltamivir) suspension
-
Tamiflu® (oseltamivir) suspension availability - 26 June 2019
Roche is experiencing high seasonal demand for Tamiflu® (oseltamivir) due to the current influenza outbreak. As a result of this increased demand, Roche is anticipating a temporary shortage of Tamiflu 6 mg/ml suspension during July. Tamiflu continues to be available in 30mg, 45mg and 75mg capsules to treat cases of influenza throughout Australia.
Where no suspension is available, Tamiflu capsules may be compounded by a pharmacy. Pharmacists should refer to instructions in the Tamiflu capsules Product Information or the How to prepare Tamiflu suspension information sheet.
Roche is working closely with its global supply chain team to secure additional stock, and with its distribution partner, Apotex, to expedite deliveries to ensure wholesalers have the stock they need. Wholesalers are advised to contact Apotex, for further information on supply of Tamiflu. Pharmacists are advised to contact their usual wholesaler, or an alternative wholesaler, in the event that they cannot secure supply. Pharmacists may also contact Apotex Customer Services directly on 1800 276 839 or by email at: customer.service.aus@apotex.com to identify an alternative wholesaler.
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tarceva® (erlotinib)
-
Tarceva® (erlotinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tecentriq® (atezolizumab)
-
Tecentriq® (atezolizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Valcyte® (valganciclovir) powder for oral solution
-
Valcyte® (valganciclovir) powder for oral solution
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Valcyte® (valganciclovir) tablets
-
Valcyte® (valganciclovir) tablets
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Valium® (diazepam)
-
Valium® (diazepam)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Xenical® (orlistat)
-
Xenical® (orlistat)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Zelboraf® (vemurafenib)
-
Zelboraf® (vemurafenib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI)